Submitted by Anonymous (not verified) on 30 November 2023 - 9:03
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Radionuclide Imaging;Alzheimer Disease, Date of authorisation: 20/02/2014, Revision: 20, Status: Authorised
Source: